Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2018, Vol. 12 ›› Issue (08): 477-482. doi: 10.3877/cma.j.issn.1674-0785.2018.08.010

Special Issue:

• Evidence-based Medicine • Previous Articles    

Efficacy of autologous hematopoietic stem cell transplantation in treatment of new onset type 1 diabetes mellitus: a meta-analysis

Zhiwei Zou1, Xiaojun Zhou2, Junyu Zhao2, Rui Zhang2, Chunmei Xu2, Qian Zhang1, Lin Liao2, Jianjun Dong1,()   

  1. 1. Department of Endocrinology, Qilu Hospital of Shandong University, Jinan 250012, China
    2. Department of Endocrinology, Shandong University Affiliated Qianfoshan Hospital, Jinan 250014, China
  • Received:2018-03-30 Online:2018-04-15 Published:2018-04-15
  • Contact: Jianjun Dong
  • About author:
    Corresponding author: Dong Jianjun, E-mail:

Abstract:

Objective

To investigate the efficacy of autologous hematopoietic stem cell transplantation in the treatment of type 1 diabetes mellitus.

Methods

Databases were searched with the terms autologous hematopoietic stem cell transplantation and type 1 diabetes mellitus. According to the predefined strategy, we performed study screening, data extraction and analysis.

Results

Seven trials met the inclusion criteria (n=112). Meta-analysis showed that glycosylated hemoglobin decreased by 3.32 (95%CI: -4.25 - -2.39; P<0.001) at 12 months after autologous hematopoietic stem cell transplantation. Fasting C-peptide levels increased significantly at 6 and 12 months after autologous hematopoietic stem cell transplantation therapy (MD=0.50, 95%CI: 0.28-0.72, P<0.001; MD=0.48, 95%CI: 0.29-0.67, P<0.001). Approximately 59.4% of patients became free of the need of insulin therapy for different durations.

Conclusion

To a certain extent, autologous hematopoietic stem cell transplantation therapy for type 1 diabetes mellitus can decrease patients glycosylated hemoglobin, elevate their fasting C-peptide levels, and make patients become free of the need of insulin therapy for different durations.

Key words: Type 1 diabetes mellitus, Autologous hematopoietic stem cell transplantation, Meta-analysis

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd